Упрощенная HTML-версия
56. Bjarnason I. Intestinal toxicity of non-steroidal anti-inflammatory drugs / I.
Bjarnason, A.J. Macpherson // Pharmacol. Ther. - 1994. - Vol. 62, № 1-2. – Р. 145-157.
57. Bjarnason I. Side effects of nonsteroidal anti-inflammatory drugs on the small and
large intestine in humans / I. Bjarnason, J. Hayllar, A.J. MacPherson et al. // Gastroenterology. -
1993. - Vol. 104, № 6. – Р. 1832-1847.
58. Bolten W.W. Underestimated adverse effects of non-steroidal anti-inflammatory
drugs on the distal intestine / W.W. Bolten // Z. Rheumatol. – 2000. - Vol. 59, № 6. – Р. 370-372.
59. Chan F.K. Helicobacter pylori and Nonsteroidal anti-inflammatory drugs: A Three-
way Debate / F.K. Chan, C.J. Hawkey, A.I. Lanas // Amer. J. Med. - 2001. - Vol. 110 (1A). - Р.55-
57.
60. Chan F.K. Should we eradicate Helicobacter pylori infection in patients receiving
nonsteroidal anti-inflammatory drugs or low-dose aspirin? / F.K. Chan // Chin. J. Dig. Dis. – 2005. –
Vol. 6,№1. – Р. 1-5.
61. Chutkan R. Effect of nonsteroidal anti-inflammatory drugs on the gastrointestinal
tract: diagnosis by wireless capsule endoscopy / R. Chutkan, N Toubia // Gastrointest. Endosc. Clin.
N. Am. 2004. Vol. 14, № 1. – Р. 67-85.
62. Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori
among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-
control study / D. Tzourmakliotis, M. Economou, S. Manolakopoulos et al. // Scand. J.
Gastroenterol. – 2004. – Vol. 39,№12. – Р. 1180-1185.
63. Clofazimine induced enteropathy—a case highlighting the importance of drug
induced disease in differential diagnosis / B.S. Mathew, A.B. Pulimood, C.G. Prasanna et al. // Trop.
Gastroenterol. – 2006. – Vol. 27, №2. – Р. 87-88.
64. Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells /
Kirtikara K., Morham S.G., Raghow R. et al. // J. Exp. Med. – 1998. -N 187. – P. 517–523.
65. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2
during prevention and healing of indomethacin-induced gastric ulcer / S. Swarnakar, K. Ganguly, P.
Kundu et al. // J. Biol. Chem. – 2005. –Vol. 280,№10. – Р. 9409-9415.
66. Current concepts in the management of Helicobacter pylori infection. The Maastricht
2-2000 Consensus Report, September.— Rome, 2000.
67. Davies N.M. Detection and prevention of NSAID-induced enteropathy / N.M.
Davies, J.Y. Saleh, N.M. Skjodt // J. Pharm. Sci. - 2000. - Vol. 3, № 1. – P. 137-155.
68. Davies N.M. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine /
N.M. Davies // Dis. Colon. Rectum. - 1995. - Vol. 38, № 12. – Р. 1311-1321.
69. Does adding misoprostol to standard intravenous proton pump inhibitor protocol
improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized
prospective study / S. Yilmaz, K. Bayan, M. Dursun et al. // Dig Dis Sci. – 2007. – Vol. 52, №1. – Р.
110-118.
70. Effect of Aronia melanocarpa fruit juice on indomethacin-induced gastric mucosal
damage and oxidative stress in rats / S. Valcheva-Kuzmanova, K. Marazova, I. Krasnaliev et al. //
Exp. Toxicol. Pathol. – 2005. –Vol. 56,№6. – Р. 385-392.
71. Effect of ethanol extract of Piper betle Linn leaf on healing of NSAID-induced
experimental ulcer—a novel role of free radical scavenging action / B. Majumdar, S.G. Ray
Chaudhuri, A. Ray et al. // Indian. J. Exp. Biol. – 2003. – Vol.41,№4. – Р.311-315.
72. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced
gastroduodenal mucosal injury / A. Giral, O. Ozdogan, C.A. Celikel et al. // J. Gastroenterol.
Hepatol. – 2004. – Vol. 19,№7. – Р. 773-777.